Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtechs Concerned By Export Ban As Germany Makes Coronavirus Pandemic Move

Executive Summary

German health minister Jens Spahn has taken decisive steps in the face of the rising COVID-19 threat, but the medtech industry is critical of the government’s decision to unilaterally ban exports of certain health care products and protective equipment. 

You may also be interested in...



Indian Industry Gets HCQ, Paracetamol Exports Rolling

Indian manufacturers hope increased production of hydroxychloroquine and paracetamol, along with emergence of reliable COVID-19 therapies, will lead to export restrictions on these two medicines being removed soon. Meanwhile, they are fulfilling orders routed through the government.

EU Restricts Coronavirus PPE Equipment Exports

The rapidly escalating COVID-19 crisis in Europe – now the global 'epicenter' of coronavirus infections  ̶   has forced the European Commission to put in place export controls on personal protective equipment.

More German Companies Get To Work On COVID-19 Diagnostic Test Development

Another three in vitro diagnostics companies in Germany are working on tests for the early detection of COVID-19, with confirmed infections reaching 89,000 globally by 2 March.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel